Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model

Gishel New, Jeffrey W. Moses, Gary S. Roubin, Martin B. Leon, Antonio Colombo, Sriram S. Iyer, Fermin O. Tio, Roxana Mehran, Nicholas Kipshidze

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Estrogen can inhibit intimal proliferation and accelerate endothelial regeneration after angioplasty. This suggests that estrogen may prevent in-stent restenosis. Unlike other therapies to prevent restenosis, estrogen may also not delay endothelial regrowth, thereby avoiding the risk of late stent thrombosis. The purpose of this work was to determine the effect of a 17β-estradiol-eluting stent on neointimal formation in a porcine model. Each artery of six pigs was randomized to either a control, low-dose, or high-dose 17β-estradiol-eluting stent. All animals were sacrificed at 30 days for histopathological analysis. There was a 40% reduction in intimal area in the high-dose stents compared with control stents (2.54 ± 1.0 vs. 4.13 ± 1.1 mm2, for high dose vs. control, respectively; P <0.05). There was complete endothelial regeneration at 30 days and similar inflammatory response to stenting on histopathology in all the stent groups. This is the first study to show that 17β-estradiol-eluting stents are associated with reduced neointimal formation without affecting endothelial regeneration in the pig model of in-stent restenosis. Estrogen-coated stents may have a potential benefit in the prevention and treatment of in-stent restenosis.

Original languageEnglish
Pages (from-to)266-271
Number of pages6
JournalCatheterization and Cardiovascular Interventions
Volume57
Issue number2
DOIs
Publication statusPublished - Oct 1 2002

Fingerprint

Phosphorylcholine
Stents
Blood Vessels
Estrogens
Swine
Tunica Intima
Regeneration
Estradiol
Angioplasty
Thrombosis
Arteries

Keywords

  • Drug-eluting stent
  • Endothelium
  • Estrogen
  • Restenosis
  • Stents

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model. / New, Gishel; Moses, Jeffrey W.; Roubin, Gary S.; Leon, Martin B.; Colombo, Antonio; Iyer, Sriram S.; Tio, Fermin O.; Mehran, Roxana; Kipshidze, Nicholas.

In: Catheterization and Cardiovascular Interventions, Vol. 57, No. 2, 01.10.2002, p. 266-271.

Research output: Contribution to journalArticle

New, Gishel ; Moses, Jeffrey W. ; Roubin, Gary S. ; Leon, Martin B. ; Colombo, Antonio ; Iyer, Sriram S. ; Tio, Fermin O. ; Mehran, Roxana ; Kipshidze, Nicholas. / Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model. In: Catheterization and Cardiovascular Interventions. 2002 ; Vol. 57, No. 2. pp. 266-271.
@article{ea8befdfc9e64b69ad5a11393ec3b030,
title = "Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model",
abstract = "Estrogen can inhibit intimal proliferation and accelerate endothelial regeneration after angioplasty. This suggests that estrogen may prevent in-stent restenosis. Unlike other therapies to prevent restenosis, estrogen may also not delay endothelial regrowth, thereby avoiding the risk of late stent thrombosis. The purpose of this work was to determine the effect of a 17β-estradiol-eluting stent on neointimal formation in a porcine model. Each artery of six pigs was randomized to either a control, low-dose, or high-dose 17β-estradiol-eluting stent. All animals were sacrificed at 30 days for histopathological analysis. There was a 40{\%} reduction in intimal area in the high-dose stents compared with control stents (2.54 ± 1.0 vs. 4.13 ± 1.1 mm2, for high dose vs. control, respectively; P <0.05). There was complete endothelial regeneration at 30 days and similar inflammatory response to stenting on histopathology in all the stent groups. This is the first study to show that 17β-estradiol-eluting stents are associated with reduced neointimal formation without affecting endothelial regeneration in the pig model of in-stent restenosis. Estrogen-coated stents may have a potential benefit in the prevention and treatment of in-stent restenosis.",
keywords = "Drug-eluting stent, Endothelium, Estrogen, Restenosis, Stents",
author = "Gishel New and Moses, {Jeffrey W.} and Roubin, {Gary S.} and Leon, {Martin B.} and Antonio Colombo and Iyer, {Sriram S.} and Tio, {Fermin O.} and Roxana Mehran and Nicholas Kipshidze",
year = "2002",
month = "10",
day = "1",
doi = "10.1002/ccd.10339",
language = "English",
volume = "57",
pages = "266--271",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model

AU - New, Gishel

AU - Moses, Jeffrey W.

AU - Roubin, Gary S.

AU - Leon, Martin B.

AU - Colombo, Antonio

AU - Iyer, Sriram S.

AU - Tio, Fermin O.

AU - Mehran, Roxana

AU - Kipshidze, Nicholas

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Estrogen can inhibit intimal proliferation and accelerate endothelial regeneration after angioplasty. This suggests that estrogen may prevent in-stent restenosis. Unlike other therapies to prevent restenosis, estrogen may also not delay endothelial regrowth, thereby avoiding the risk of late stent thrombosis. The purpose of this work was to determine the effect of a 17β-estradiol-eluting stent on neointimal formation in a porcine model. Each artery of six pigs was randomized to either a control, low-dose, or high-dose 17β-estradiol-eluting stent. All animals were sacrificed at 30 days for histopathological analysis. There was a 40% reduction in intimal area in the high-dose stents compared with control stents (2.54 ± 1.0 vs. 4.13 ± 1.1 mm2, for high dose vs. control, respectively; P <0.05). There was complete endothelial regeneration at 30 days and similar inflammatory response to stenting on histopathology in all the stent groups. This is the first study to show that 17β-estradiol-eluting stents are associated with reduced neointimal formation without affecting endothelial regeneration in the pig model of in-stent restenosis. Estrogen-coated stents may have a potential benefit in the prevention and treatment of in-stent restenosis.

AB - Estrogen can inhibit intimal proliferation and accelerate endothelial regeneration after angioplasty. This suggests that estrogen may prevent in-stent restenosis. Unlike other therapies to prevent restenosis, estrogen may also not delay endothelial regrowth, thereby avoiding the risk of late stent thrombosis. The purpose of this work was to determine the effect of a 17β-estradiol-eluting stent on neointimal formation in a porcine model. Each artery of six pigs was randomized to either a control, low-dose, or high-dose 17β-estradiol-eluting stent. All animals were sacrificed at 30 days for histopathological analysis. There was a 40% reduction in intimal area in the high-dose stents compared with control stents (2.54 ± 1.0 vs. 4.13 ± 1.1 mm2, for high dose vs. control, respectively; P <0.05). There was complete endothelial regeneration at 30 days and similar inflammatory response to stenting on histopathology in all the stent groups. This is the first study to show that 17β-estradiol-eluting stents are associated with reduced neointimal formation without affecting endothelial regeneration in the pig model of in-stent restenosis. Estrogen-coated stents may have a potential benefit in the prevention and treatment of in-stent restenosis.

KW - Drug-eluting stent

KW - Endothelium

KW - Estrogen

KW - Restenosis

KW - Stents

UR - http://www.scopus.com/inward/record.url?scp=0036790743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036790743&partnerID=8YFLogxK

U2 - 10.1002/ccd.10339

DO - 10.1002/ccd.10339

M3 - Article

C2 - 12357534

AN - SCOPUS:0036790743

VL - 57

SP - 266

EP - 271

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 2

ER -